The text starts here.
Understanding Eisai

Understanding the Pharmaceutical Industry

Developing a New “Drug”

It takes many years before a new drug can be distributed on the market. On average, it takes between nine and 16 years, and only one in approximately 24,553 candidate compounds actually becomes a drug.*

Process for developing a new drug

(1) Basic Research (2-3 years)
  During this period, new substances (candidate compounds) or ingredients that have the potential to become drugs are discovered or chemically produced and evaluated.

(2) Pre-clinical Research (3-5 years)
  The efficacy and safety of candidate compounds are evaluated using cultured cells and animals.

(3) Clinical studies (3-7 years)
  During this phase, the efficacy and safety in humans of the candidate compounds that passed the pre-clinical research phase are confirmed. The following steps are performed at hospitals and other healthcare institutions on individuals who consent to participate in the clinical trial.
Phase I
Generally, safety including possible side effects is confirmed on a small number of healthy individuals.
Phase II
Effective and safe doses as well as administration methods are confirmed on a small number of patients.
Phase III
Efficacy and safety are investigated on a large number of patients by comparison with a placebo or existing drugs.

(4) Application for Approval and Review (1-2 years)
  After the efficacy, safety and quality of the candidate compound are confirmed, an application is submitted to regulatory agencies such as the Ministry of Health, Labour and Welfare in Japan, and the agency conducts a review.

(5) Approval and Sales
  Approval to manufacture and market the drug is obtained after going through a regulatory review. The methods for determining the price of the drug vary from country to country, but in many cases, the government determines the price. In Japan, the categories and prices of prescription drugs that are covered by national and social health insurance are determined by the Ministry of Health, Labour and Welfare in accordance with a drug pricing standards system.

(6) Post Marketing Studies: Phase IV
  Information concerning adverse events that can be discovered only after a drug is used by numerous patients at healthcare institutions, as well as information concerning appropriate usage, is continuously collected. This information can be used for subsequent improvements as well as to provide hints for future drug development.

* According to 5 years of cumulative statistics (fiscal 2010 - 2014) compiled by the Japan Pharmaceutical Manufacturers Association.

Patent Term and Generic Drugs

The efficacy and safety of new drugs are confirmed through extensive research and development at considerable expense, and drugs receive approval for sale from national governments as described above. There are periods, which vary from country to country, during which the manufacturer has the exclusive right to sell the effective ingredients of a drug, such as the valid period of a composition of matter patent or the renewal period of such a patent, but when those periods expire other pharmaceutical companies can manufacture and sell drugs with the same active ingredients. These drugs are called “generic drugs.”

What is the Future of the Pharmaceutical Industry?

Given the massive development costs that it faces, the pharmaceutical industry in Japan is undergoing changes, such as restructuring through mergers and acquisitions, and as a result the business environment in which pharmaceutical companies find themselves is transforming rapidly. However, of the approximately 30,000 known diseases (as classified by the WHO), treatments are known for only about one third. Under these circumstances, much is expected of the pharmaceutical industry as a strategic industry for Japan in the twenty-first century.

For more detailed information:
View detailed information Check Eisai glossaryList

Click here for expressions associated with this page
Compound (of matter) patentOpen a separeate window
Drug priceOpen a separeate window
GenericsOpen a separeate window
Prescription pharmaceuticalsOpen a separeate window

   Understanding Eisai

Related Links